V-Square Quantitative Management’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$855K Buy
5,970
+1,997
+50% +$281K 0.08% 219
2026
Q1
$521K Buy
3,973
+92
+2% +$13.2K 0.06% 311
2025
Q4
$515K Buy
+3,881
New +$515K 0.05% 307
2025
Q3
Sell
-3,478
Closed -$464K 293
2025
Q2
$464K Sell
3,478
-657
-16% -$75.4K 0.06% 311
2025
Q1
$453K Sell
4,135
-100
-2% -$12.1K 0.07% 316
2024
Q4
$525K Buy
4,235
+258
+6% +$31.3K 0.07% 283
2024
Q3
$435K Buy
3,977
+1,792
+82% +$193K 0.06% 327
2024
Q2
$241K Sell
2,185
-7,183
-77% -$794K 0.04% 415
2024
Q1
$1.06M Hold
9,368
0.15% 113
2023
Q4
$912K Buy
9,368
+2,530
+37% +$232K 0.16% 90
2023
Q3
$660K Buy
6,838
+2,287
+50% +$218K 0.29% 61
2023
Q2
$411K Buy
+4,551
New +$383K 0.3% 65

Other funds holding EMR

V-Square Quantitative Management's EMR Position: Q2 2026 in Review

V-Square Quantitative Management increased its Emerson Electric (EMR) stake by 50% in Q2 2026, buying an estimated $281K and bringing the position to 5,970 shares worth $855K. The position accounts for 0.08% of the portfolio, ranked #219.

V-Square Quantitative Management first reported a position in EMR in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.06M in Q1 2024. 988 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • V-Square Quantitative Management held 5,970 shares of Emerson Electric worth $855K as of Q2 2026.
  • V-Square Quantitative Management bought 1,997 Emerson Electric shares in Q2 2026, an estimated $281K.
  • Emerson Electric made up 0.08% of V-Square Quantitative Management's portfolio in Q2 2026, its #219 holding.
  • V-Square Quantitative Management first reported a position in Emerson Electric in Q2 2023 and has held it in 12 quarters since.
  • V-Square Quantitative Management's Emerson Electric position peaked at $1.06M in Q1 2024.
  • 988 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.